As of Oct 02
| +0.29 / +13.36%|
The 3 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 9.00, with a high estimate of 11.00 and a low estimate of 5.00. The median estimate represents a +265.85% increase from the last price of 2.46.
The current consensus among 3 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.